Label: information for the user
Humalog Mix50 100 units/mL injectable suspension in cartridge
insulin lispro
Read this label carefully before starting to use this medication, as it contains important information for you.
Humalog Mix50 is used to treat diabetes. Humalog Mix50 is a pre-mixed suspension. Its active ingredient is insulin lispro. In Humalog Mix50, 50% of insulin lispro has been dissolved in water and works faster than normal human insulin because the insulin molecule has been slightly changed. In Humalog Mix50, a suspension of 50% insulin lispro has been incorporated along with protamine sulfate, to prolong its action.
You have diabetes when your pancreas does not produce enough insulin to control your blood glucose level. Humalog Mix50 is a substitute for your own insulin and is used to control glucose levels in the long term. Humalog Mix50 acts very quickly and for a longer time than soluble insulin. Normally, you should use Humalog Mix50 within 15 minutes around a meal.
Your doctor may recommend using Humalog Mix50 with a longer-acting insulin. Each one comes with its own leaflet with specific information. Do not change your insulin unless your doctor tells you to. Be very careful when changing insulin.
Do not use Humalog Mix50
Warnings and precautions
?Have you recently been ill?
?Do you have liver or kidney problems?
?Are you doing more exercise than usual?
Changes in skin at the injection site
The injection site should be rotated to avoid changes in the skin, such as lumps under the skin. Insulin may not work well if injected into a swollen area (see How to use Humalog Mix50). Please contact your doctor if you are currently injecting into a swollen area, before starting to inject into a different area. Your doctor may instruct you to closely monitor your blood sugar levels and adjust your insulin or other antidiabetic medications.
Other medicines and Humalog Mix50
Your insulin needs may change if
Please inform your doctor if you are using, have recently used, or may need to use any other medicine, even those purchased without a prescription (see Section “Warnings and precautions”).
Pregnancy and breastfeeding
Are you pregnant or planning to become pregnant? Are you breastfeeding? The amount of insulin you need usually decreases during the first three months of pregnancy and increases during the next six months. If you are breastfeeding, you may need to adjust your insulin dose or diet. If you are pregnant or breastfeeding, or think you may be pregnant, please consult your doctor or pharmacist before using this medicine.
Driving and operating machinery
Your ability to concentrate or react may be reduced if you experience hypoglycemia. Be aware of this possible problem, considering all situations that may pose a risk to you or others (e.g. driving a vehicle or operating machinery). You should consult your doctor about the advisability of driving if you have:
Humalog Mix50 contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially “sodium-free”.
The 3 ml cartridges are for exclusive use in Lilly 3 ml pens. Do not use in 1.5 ml pens.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor again. To prevent possible transmission of diseases, each cartridge must be used only by you, even if you change the needle of the device.
Dose
How to prepare Humalog Mix50
How to prepare the pen
How to inject Humalog Mix50
After the injection
Subsequent injections
Do not mix any other insulin with a Humalog Mix50 cartridge. When this cartridge is empty, it cannot be used again.
If you use more Humalog Mix50 than you need
If you use more Humalog Mix50 than you need or are unsure of how much you have injected, you may have low blood sugar. Check your blood sugar.
If your blood sugar is low (mild hypoglycemia), take glucose tablets, sugar, or a sweet drink. Then, eat fruit, cookies, or a snack, as your doctor has instructed, and rest afterwards. This usually helps you recover from mild hypoglycemia or a small overdose of insulin. If you get worse and your breathing is shallow and your skin is pale, call your doctor immediately. Severe hypoglycemia can be treated with a glucagon injection. After the glucagon injection, take glucose or sugar. If you do not respond to glucagon, you should go to the hospital. Ask your doctor to inform you about glucagon.
If you forget to use Humalog Mix50
If you use less Humalog Mix50 than you need or are unsure of how much you have injected, you may have high blood sugar. Check your blood sugar.
If not treated properly, hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) can be very serious and cause headaches, nausea, vomiting, dehydration, loss of consciousness, coma, and even death (see A and B in section 4 "Possible side effects").
Three simple measures to prevent hypoglycemia or hyperglycemiaare:
If you interrupt treatment with Humalog Mix50
If you use less Humalog Mix50 than you need, you may have high blood sugar. Do not change insulin unless your doctor tells you to.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Systemic allergy is rare (≥1/10,000 to <1
|
|
|
|
|
|
If you think you are experiencing this type of allergy with Humalog Mix50, speak immediately with your doctor.
Localized allergy is frequent (≥ 1/100 to <1
Lipodystrophy is infrequent (≥ 1/1,000 to <1amyloidosis cutis). Insulin may not work well if injected into a swollen area. Change the injection site to help prevent these skin changes.
Cases of edema (e.g. swelling in the arms, ankles; fluid retention) have been reported, especially at the beginning of insulin treatment or during a change in treatment to improve blood sugar control.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Common problems of diabetes
Hypoglycemia (low blood sugar) means that you do not have enough sugar in your blood.
It can be caused by:
Alcohol and certain medications can affect your blood sugar levels.
The first symptoms of low blood sugar usually appear suddenly and are accompanied by:
|
|
|
|
|
|
Until you are sure of recognizing the alarm symptoms, avoid situations (e.g. driving a car) in which you or others may be put in danger if hypoglycemia occurs.
Hyperglycemia (high blood sugar) means that the body does not have enough insulin. Hyperglycemia can be caused by:
Hyperglycemia can lead to diabetic ketoacidosis. The first symptoms appear slowly, over many hours or several days. Among these symptoms are the following:
|
|
|
|
|
|
Severe symptoms are deep breathing and rapid pulse.Get medical help immediately.
If you are ill, especially if you have nausea or vomiting, the amount of insulin you need may vary.Although you are not eating as usual, you still need to receive insulin. Get urine or blood tests, follow the instructions given to you when you are ill, and call your doctor.
Before first use, store Humalog Mix50 in the refrigerator (between 2°C and 8°C). Do not freeze.
Conserve your pen in use at room temperature (below 30°C) and discard after 28 days. Do not leave it near any heat source or in direct sunlight. Do not store your pen or the cartridges you are using in the refrigerator. The pen with the cartridge incorporated should not be stored with the needle attached.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label and on the packaging. The expiration date is the last day of the month indicated.
Do not use this medication if you observe lumps or white solid particles stuck to the bottom or walls of the cartridge, giving it a appearance similar to frost. Check it every time you inject.
Medicines should not be thrown down the drains or in the trash. Ask your pharmacist how to dispose of the packaging and the medications you no longer need. This way, you will help protect the environment.
Composition of Humalog Mix50 100 units/mL suspension for injection in cartridge
Appearance of the product and contents of the pack
Humalog Mix50 100 units/mL suspension for injection is a white, sterile suspension containing 100 units of insulin lispro in each milliliter of suspension for injection (100 units/mL). In Humalog Mix50, 50% of insulin lispro has been dissolved in water. A 50% suspension of insulin lispro has been incorporated along with protamine sulfate. Each cartridge contains 300 units (3 milliliters). The packs contain 5 or 10 cartridges. Not all presentations may be marketed.
Holder of the marketing authorization and responsible manufacturer
Humalog Mix50 100 units/mL suspension for injection in cartridge is manufactured by:
The holder of the marketing authorization is Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands.
For more information about this medicine, please contact the local representative of the marketing authorization holder:
Belgium/België/Belgien Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | Lithuania Eli Lilly Lietuva Tel: +370 (5) 2649600 |
Luxembourg/Luxemburg Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | |
Czech Republic ELI LILLY CR, s.r.o. Tel: + 420 234 664 111 | Hungary Lilly Hungária Kft. Tel: + 36 1 328 5100 |
Denmark Eli Lilly Danmark A/S Tlf: +45 45 26 6000 | Malta Charles de Giorgio Ltd. Tel: + 356 25600 500 |
Germany Lilly Deutschland GmbH Tel: + 49-(0) 6172 273 2222 | Netherlands Eli Lilly Nederland B.V. Tel: + 31-(0) 30 60 25 800 |
Estonia Eli Lilly Nederland B.V. Tel: +372 6817 280 | Norway Eli Lilly Norge A.S. Tlf: + 47 22 88 18 00 |
Greece ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε. Tel: +30 210 629 4600 | Austria Eli Lilly Ges. m.b.H. Tel: + 43-(0) 1 711 780 |
Spain Lilly S.A. Tel: + 34-91 663 50 00 | Poland Eli Lilly Polska Sp. z o.o. Tel: +48 22 440 33 00 |
France Lilly France Tel: +33-(0) 1 55 49 34 34 | Portugal Lilly Portugal - Produtos Farmacêuticos, Lda Tel: + 351-21-4126600 |
Croatia Eli Lilly Hrvatska d.o.o. Tel: +385 1 2350 999 | Romania Eli Lilly România S.R.L. Tel: + 40 21 4023000 |
Ireland Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 | Slovenia Eli Lilly farmacevtska družba, d.o.o. Tel: +386 (0) 1 580 00 10 |
Iceland Icepharma hf. Tel: + 354 540 8000 | Slovakia Eli Lilly Slovakia s.r.o. Tel: + 421 220 663 111 |
Italy Eli Lilly Italia S.p.A. Tel: + 39- 055 42571 | Finland Oy Eli Lilly Finland Ab Tel: + 358-(0) 9 85 45 250 |
Cyprus Phadisco Ltd Tel: +357 22 715000 | Sweden Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 |
Lithuania Eli Lilly (Suisse) S.A Parstavnieciba Latvija Tel: +371 67364000 | United Kingdom (Northern Ireland) Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 |
Last review date of this leaflet:
The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.